Advicenne announces commercialization agreement with FrostPharma AB for Sibnayal™ in the Nordic region | Morningstar
Published on: Monday 03 January 2022
Advicenne (Euronext: ADVIC) (or the "Company"), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, is ...
